XENE

NASDAQ · Biotechnology

Xenon Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$39.75

-17.60 (-30.69%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 25 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target -49.7% upside

Low Target $12.55

Average Target $19.98

High Target $22.13

Current Price $39.75

Current
$39.75

Target
$19.98

$12.55 $19.98 avg $22.13

Scenario Analysis

Bear Case

$12.55

-68.4%

Low target

Base Case

$19.98

-49.7%

Avg target

Bull Case

$22.13

+-44.3%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$72.66

-45.3% from high

52-Week Low

$35.97

+10.5% from low

50-Day SMA

$42.54

-6.6% vs SMA

200-Day SMA

$37.78

+5.2% vs SMA

RSI (14)

57.5

Neutral

Target vs 52W High

$19.98

-72.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.4%
AMGN Amgen Inc	Hold	43	47%	$190.87	-50.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-3.0%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%